The compact, mobile design and engineering of TRON for medical imaging marks a milestone toward democratizing access to diagnostic imaging
Since 2001, Xoran is the pioneer and medical market leader in low-dose radiation, cone beam CT systems specifically designed for the patient’s point-of-care. (Credit: Xoran Technologies, LLC)
Xoran Technologies announces its recent submission of an FDA 510(k) application for TRONTM—a mobile, open-bore fluoroscopy cone beam computed tomography (CT) for full-body point-of-care imaging.
This month Xoran also announced that it had begun work on Phase 2 of its mobile lung grant—the goal of which is to confirm the safety and utility of a future thoracic point-of-care CT system in support of an FDA submission. These research and development efforts for lung CT are supported by a recent grant award from the National Heart, Lung, and Blood Institute (NHLBI) through the National Institutes of Health (NIH).
The compact, mobile design and engineering of TRON for medical imaging marks a milestone toward democratizing access to diagnostic imaging.
“The TRON device submission is a huge step for Xoran in terms of expanding our imaging capability overall,” says Misha Rakic, Xoran CEO. “With this thru-bore CT that is truly mobile, compact, and able to perform low dose imaging, we’re expanding our existing competence out of the realm of ‘head only’ CT and progressing to imaging the entire body.”
Source: Company Press Release